Lilly Not Interested in Buying Parts of Abbott, Lechleiter Says

Eli Lilly & Co. (LLY) isn’t interested in buying parts of Abbott Laboratories (ABT) when it splits next year, Lilly’s chief executive officer said.

“We don’t believe large-scale combinations like that will add value for Lilly,” John Lechleiter said in a telephone interview today. “We remain focused on our strategy, which includes smaller deals and alliances.”

To contact the reporter on this story: Simeon Bennett in Geneva at

To contact the editor responsible for this story: Phil Serafino at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.